Clinical Trials Directory

Trials / Unknown

UnknownNCT05392725

Epidemiological Study on Malignancy Complicated With Renal Injury

Status
Unknown
Phase
Study type
Observational
Enrollment
30,000 (estimated)
Sponsor
RenJi Hospital · Academic / Other
Sex
All
Age
18 Years – 80 Years
Healthy volunteers
Not accepted

Summary

The epidemiological study of tumor complicated with kidney disease can clarify the prevalence and risk factors of renal injury when malignant tumor is diagnosed, and understand the impact of malignant tumor complicated with renal injury on survival time. This study will bring enlightenment to clinicians, discover high-risk factors in time, and try to avoid renal damage factors in diagnosis and treatment. Early diagnosis and early treatment can partially terminate the progress of renal injury, avoid the suspension of treatment due to renal reasons, and avoid the occurrence of end-stage renal failure (ESRD).

Detailed description

1. To determine the prevalence of malignant tumor complicated with renal injury and analyze the related risk factors. 2. To compare the survival time of malignant tumor with or without renal injury

Conditions

Timeline

Start date
2022-12-01
Primary completion
2024-12-01
Completion
2024-12-01
First posted
2022-05-26
Last updated
2022-05-26

Source: ClinicalTrials.gov record NCT05392725. Inclusion in this directory is not an endorsement.

Epidemiological Study on Malignancy Complicated With Renal Injury (NCT05392725) · Clinical Trials Directory